Journal
ANAIS BRASILEIROS DE DERMATOLOGIA
Volume 84, Issue 6, Pages 695-697Publisher
SOC BRASILEIRA DERMATOLOGIA
DOI: 10.1590/S0365-05962009000600022
Keywords
Antibodies, monoclonal; Hidradenitis; Tumor necrosis factor-alfa
Categories
Ask authors/readers for more resources
Hidradenitis suppurativa is an inflammatory disease with difficult treatment. Currently, the anti-TNF alfa therapy, with monoclonal antibodies (biological therapy), has been shown as a new alternative. However, clinical trials assessing the efficacy of these drugs to treat hidradenitis suppurativa have not yet been published. A case in which the use of infliximab did not result in significant clinical improvement is described.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available